Calcitonin gene-related peptide: Understanding its role

Indian Journal of Pharmacology

Volumn 36, Issue 5, 2004, Pages 277-283

  Ghatta, Srinivas ^a   Nimmagadda, D ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Calcitonin receptor like receptor; cAMP; CGRP receptor; Signal transduction

Indexed keywords

ALPHA ACTIN; AMINO ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIBN 4096 BS; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; ESTROGEN; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; GLYCERYL TRINITRATE; NERVE GROWTH FACTOR; NEUROPEPTIDE; NITRIC OXIDE; PROGESTERONE; RECEPTOR ACTIVITY MODIFYING PROTEIN; RECEPTOR BLOCKING AGENT; RECEPTOR PROTEIN; RECEPTOR SUBTYPE; SB 273779; STEROID HORMONE; SUMATRIPTAN; UNCLASSIFIED DRUG; WO 98 11128;

CARDIOVASCULAR EFFECT; CLINICAL TRIAL; DRUG DESIGN; DRUG RECEPTOR BINDING; GASTROINTESTINAL DISEASE; HEART PROTECTION; HUMAN; MIGRAINE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PULMONARY HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION;

EID: 7444221866     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Amara SG, Arriza JL, Leff SE, Swanson LW, Evans RM, Rosenfeld MG. Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Sci 1985;229:1094-7.
2. Durham PL. CGRP-receptor antagonists-a fresh approach to migraine therapy? N Engl J Ed 2004;350:1073-5.
3. Edvinsson L. Calcitonin gene-related peptide (CGRP) in cerebrovascular disease. Sci World J 2002;2:1484-90.
4. Wu D, Doods H, Arndt K, Schindler M. Development and potential of non-peptide antagonists for calcitonin-gene-related peptide (CGRP) receptors: Evidence for CGRP receptor heterogeneity. Biochem Soc Trans 2002;30:468-73.
5. Conner AC, Hay DL, Howitt SG, Kilk K, Langel U, Wheatley M, et al. Interaction of calcitonin-gene-related peptide with its receptors. Biochem Soc Trans 2002;30:451-5.
6. Harzenetter MD, Keller U, Beer S, Riedl C, Peschel C, Holzmann B. Regulation and function of the CGRP receptor complex in human granulopoiesis. Exp Hematol 2002;30:306-12.
7. Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 2000;275:31438-43.
8. Chauhan M, Thota CS, Kondapaka S, Wimalawansa S, Yallampalli C. Evidence for the existence of a new receptor for CGRP, which is not CRLR. Peptides 2003;24:65-71.
9. Dennis T, Fournier A, St Pierre S, Quirion R. Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther 1989;251:718-25.
10. Poyner D, Marshall I. CGRP receptors: Beyond the CGRP (1)-CGRP (2) subdivision? Trends Pharmacol Sci 2001;22:223.
11. Dumont Y, Chabot JG, Quirion R. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: Focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides. Peptides 2004;25:365-91.
12. Wisskirchen FM, Gray DW, Marshall I. Receptors mediating CGRP-induced relaxation in the rat isolated thoracic aorta and porcine isolated coronary artery differentiated by h(alpha) CGRP(8-37). Br J Pharmacol 1999;128:283-92.
13. Dennis T, Fournier A, Cadieux A, Pomerleau F, Jolicoeur FB, St Pierre S, et al. hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther 1990;254:123-8.
14. Wisskirchen FM, Burt RP, Marshall I. Pharmacological characterization of CGRP receptors mediating relaxation of the rat pulmonary artery and inhibition of twitch responses of the rat vas deferens. Br J Pharmacol 1998;123:1673-83.
15. Sheykhzade M, Nyborg NC. Characterization of calcitonin gene-related peptide (CGRP) receptors in intramural coronary arteries from male and female Sprague Dawley rats. Br J Pharmacol 1998;123:1464-70.
16. Lei S, Mulvany MJ, Nyborg NC. Characterization of the CGRP receptor and mechanisms of action in rat mesenteric small arteries. Pharmacol Toxicol 1994;74:130-5.
17. Nishimura Y, Suzuki A. Relaxant effects of vasodilator peptides on isolated basilar arteries from stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1997;24:157-61.
18. Nuki C, Kawasaki H, Takasaki K, Wada A. Structure-activity study of chicken calcitonin gene-related peptide (CGRP) on vasorelaxation in rat mesenteric resistance vessels. Jpn J Pharmacol 1994;65:99-105.
19. Chin SY, Hall JM, Brain SD, Morton IK. Vasodilator responses to calcitonin gene-related peptide (CGRP) and amylin in the rat isolated perfused kidney are mediated via CGRP1 receptors. J Pharmacol Exp Ther 1994;269:989-92.
20. Entzeroth M, Doods HN, Wieland HA, Wienen W. Adrenomedullin mediates vasodilation via CGRP1 receptors. Life Sci 1995;56:19-25.
21. Casini A, Galli G, Salzano R, Santicioli P, Maggi CA, Rotella CM, et al. Calcitonin gene-related peptide increases the production of glycosaminoglycans but not of collagen type I and III in cultures of rat fat-storing cells. Life Sci 1991;49:163-8.
22. Bell D, McDermott BJ. Calcitonin gene-related peptide stimulates a positive contractile response in rat ventricular cardiomyocytes. J Cardiovasc Pharmacol 1994;23:1011-21.
23. Eguchi S, Hirata Y, Kano H, Sato K, Watanabe Y, Watanabe TX, et al. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994;340:226-30.
24. Chiba T, Yamaguchi A, Yamatani T, Nakamura A, Morishita T, Inui T, et al. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol 1989;256:331-5.
25. Aiyar N, Griffin E, Albrightson-Winslow C, Feuerstein G, Nambi P. Homologous desensitization of calcitonin gene-related peptide response in rat glomerular mesangial cells in culture. Mol Cell Biochem 1992;113:17-23.
26. Poyner DR, Andrew DP, Brown D, Bose C, Hanley MR. Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes. Br J Pharmacol 1992;105:441-7.
27. Foulkes R, Shaw N, Bose C, Hughes B. Differential vasodilator profile of calcitonin gene-related peptide in porcine large and small diameter coronary artery rings. Eur J Pharmacol 1991;201:143-9.
28. Yoshimoto R, Mitsui-Saito M, Ozaki H, Karaki H. Effects of adrenomedullin and calcitonin gene-related peptide on contractions of the rat aorta and porcine coronary artery. Br J Pharmacol 1998;123:1645-54.
29. Saha S, Waugh DJ, Zhao P, Abel PW, Smith DD. Role of conformational constraints of position 7 of the disulphide bridge of h-alpha-CGRP derivatives in their agonist versus antagonist properties. J Pept Res 1998;52:112-20.
30. Tomlinson AE, Poyner DR. Multiple receptors for calcitonin gene-related peptide and amylin on guinea-pig ileum and vas deferens. Br J Pharmacol 1996;117:1362-8.
31. Giuliani S, Wimalawansa SJ, Maggi CA. Involvement of multiple receptors in the biological effects of calcitonin gene-related peptide and amylin in rat and guinea-pig preparations. Br J Pharmacol 1992;107:510-4.
32. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56.
33. Prado MA, Evans-Bain B, Oliver KR, Dickerson IM. The role of the CGRP-receptor component protein (RCP) in adrenomedullin receptor signal transduction. Peptides 2001;22:1773-81.
34. Schaeffer C, Vandroux D, Thomassin L, Athias P, Rochette L, Connat JL. Calcitonin gene-related peptide partly protects cultured smooth muscle cells from apoptosis induced by an oxidative stress via activation of ERK1/2 MAPK. Biochim Biophys Acta 2003; 1643:65-73.
35. Rossi SG, Dickerson IM, Rotundo RL. Localization of the calcitonin gene-related peptide receptor complex at the vertebrate neuromuscular junction and its role in regulating acetylcholinesterase expression. J Biol Chem 2003;278:24994-5000.
36. Miyoshi H, Nakaya Y. Calcitonin gene-related peptide activates the K+ channels of vascular smooth muscle cells via adenylate cyclase. Basic Res Cardiol 1995;90:332-6.
37. Kuo T, Ouchi Y, Kim S, Toba K, Orimo H. The role of activation of the sympathetic nervous system in the central pressor action of calcitonin gene-related peptide in conscious rats. Naunyn Schmiedebergs Arch Pharmacol 1994;349:394-400.
38. Oliver KR, Wainwright A, Edvinsson L, Pickard JD, Hill RG. Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 2002;22:620-9.
39. Edvinsson L, Goadsby PJ. Neuropeptides in migraine and cluster headache. Cephalalgia 1994;14:320-7.
40. Durham PL, Russo AF. Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci 2003;23:807-15.
41. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004;350:1104-10.
42. Keith IM, Pelto-Huikko M, Schalling M, Hokfelt T. Calcitonin gene-related peptide and its mRNA in pulmonary neuroendocrine cells and ganglia. Histochemistry 1991;96:311-5.
43. Berger A. PAR2 antagonists-the next generation of antiinflammatories? Br Med J 2000;320:334.
44. Solway J, Leff AR. Sensory neuropeptides and airway function. J Appl Physiol 1991;71:2077-87.
45. Springer J, Amadesi S, Trevisani M, Harrison S, Dinh QT, McGregor GP, et al. Effects of alpha calcitonin gene-related peptide in human bronchial smooth muscle and pulmonary artery. Regul Pept 2004;118:127-34.
46. Keith IM, Tjen-A-Looi S, Kraiczi H, Ekman R. Three-week neonatal hypoxia reduces blood CGRP and causes persistent pulmonary hypertension in rats. Am J Physiol Heart Circ Physiol 2000;279:1571-8.
47. Keith IM. The role of endogenous lung neuropeptides in regulation of the pulmonary circulation. Physiol Res 2000;49:519-37.
48. Kawashima K, Ishihara S, Karim Rumi MA, Moriyama N, Kazumori H, Suetsugu H, et al. Localization of calcitonin gene-related peptide receptors in rat gastric mucosa. Peptides 2002;23:955-66.
49. L'Heureux MC, St-Pierre S, Trudel L, Plourde V, Lepage R, Poitras P. Digestive motor effects and vascular actions of CGRP in dog are expressed by different receptor subtypes. Peptides 2000;21:425-30.
50. Lutz TA, Rossi R, Althaus J, Del Prete E, Scharrer E. Evidence for a physiological role of central calcitonin gene-related peptide (CGRP) receptors in the control of food intake in rats. Neurosci Lett 1997;230:159-62.
51. McGillis JP, Humphreys S, Reid S. Characterization of functional calcitonin gene-related peptide receptors on rat lymphocytes. J Immunol 1991;147:3482-9.
52. Martinez A, Kapas S, Miller MJ, Ward Y, Cuttitta F. Coexpression of receptors for adrenomedullin, calcitonin gene-related peptide, and amylin in pancreatic beta-cells. Endocrinology 2000;141:406-11.
53. She F, Sun W, Mao JM, Wang X. Calcitonin gene-related peptide gene therapy suppresses reactive oxygen species in the pancreas and prevents mice from autoimmune diabetes. Sheng Li Xue Bao 2003;55:625-32.
54. Kanai S, Masuda M, Suzuki S, Ohta M, Yoshida Y, Funakoshi A, et al. Inhibitory effect of central calcitonin-gene related peptide (CGRP) on pancreatic secretion in conscious rats. Jpn J Physiol 2000;50:243-8.
55. Dong YL, Fang L, Kondapaka S, Gangula PR, Wimalawansa SJ, Yallampalli C. Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy. J Clin Invest 1999;104: 559-65.
56. Thota C, Gangula PR, Dong YL, Yallampalli C. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments. Biol Reprod 2003;69:1432-7.
57. Dong YL, Vegiraju S, Gangula PR, Kondapaka SB, Wimalawansa SJ, Yallampalli C. Expression and regulation of calcitonin gene-related Peptide receptor in rat placentas. Biol Reprod 2002;67:1321-6.
58. Gangula PR, Zhao H, Wimalawansa SJ, Supowit SC, DiPette DJ, Yallampalli C. Pregnancy and steroid hormones enhance the systemic and regional hemodynamic effects of calcitonin gene-related peptide in rats. Biol Reprod 2001;64:1776-83.
59. Valentini A, Petraglia F, De Vita D, Nappi C, Margutti A, degli Uberti EC, et al. Changes of plasma calcitonin gene-related peptide levels in postmenopausal women. Am J Obstet Gynecol 1996;175:638-42.
60. Balkan W, Oates EL, Howard GA, Roos BA. Testes exhibit elevated expression of calcitonin gene-related peptide receptor component protein. Endocrinology 1999;40:1459-69.
61. Franco-Cereceda A, Gennari C, Nami R, Agnusdei D, Pernow J, Lundberg A et al. Cardiovascular effects of calcitonin gene-related peptides I and II in man. Circ Res 1987;60:393-7.
62. Siren AL, Feuerstein G. Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat. J Pharmacol Exp Ther 1988;247:69-78.
63. Takenaga M, Kawasaki H, Wada A, Eto T. Calcitonin gene-related peptide mediates acetylcholine-induced endothelium-independent vasodilation in mesenteric resistance blood vessels of the rat. Circ Res 1995;76:935-41.
64. Sigrist S, Franco-Cereceda A, Muff R, Henke H, Lundberg JM, Fischer JA. Specific receptor and cardiovascular effects of calcitonin gene-related peptide. Endocrinology 1986;119:381-9.
65. Shen YT, Pittman TJ, Buie PS, Bolduc DL, Kane SA, Koblan KS, et al. Functional role of α-calcitonin gene-related peptide in the regulation of the cardiovascular system. J Pharmacol Exp Ther 2001;298:551-8.
66. Aiyar N, Daines RA, Disa J, Chambers PA, Sauermelch CF, Quiniou M, et al. Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist. J Pharmacol Exp Ther 2001;296:768-75.
67. Autelitano DJ. Cardiac expression of genes encoding putative adrenomedullin/calcitonin gene-related peptide receptors. Biochem Biophys Res Commun 1998;250:689-93.
68. Chen IJ, Yeh JL, Lo YC, Sheu SH, Lin YT. Capsinolol: The first β-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart. Br J Pharmacol 1996;119:7-14.
69. Bell D, Tamamori M, Marumo F, Hiroe M, McDermott BJ, Ito H. Calcitonin gene-related peptide (CGRP) increases cell surface area and induces expression of skeletal α-actin ANP mRNA in hypertrophying neonatal cardiomyocytes. Regul Pept 1997;71:1-7.
70. Chang Y, Stover SR, Hoover DB. Regional localization and abundance of calcitonin gene-related peptide receptors in guinea pig heart. J Mol Cell Cardiol 2001;33:745-54.
71. Saetrum Opgaard O, de Vries R, Tom B, Edvinsson L, Saxena PR. Positive inotropy of calcitonin gene-related peptide and amylin on porcine isolated myocardium. Eur J Pharmacol 1999;385:147-54.
72. Bell D, McDermott BJ. Calcitonin gene-related peptide stimulates a positive contractile response in rat ventricular cardiomyocytes. J Cardiovasc Pharmacol 1994;23:1011-21.
73. L'Heureux MC, St-Pierre S, Trudel L, Plourde V, Lepage R, Poitras P. Digestive motor effects and vascular actions of CGRP in dog are expressed by different receptor subtypes. Peptides 2000;21:425-30.
74. Alvis AG, Milesi V, Rebolledo A, Raingo J, Grassi de Gende AO. Influence of calcitonin gene-related peptide release on pH-induced mechanical depression in rat atria. Jpn Heart J 2001;42:507-17.
75. Li YJ, Du YH. CGRP-mediated cardiovascular effect of nitroglycerin. Med Hypotheses 2003;60:693-8.
76. Booth BP, Fung HL. Contribution of vascular tissue to the antiplatelet activity of sodium nitroprusside. J Cardiovasc Pharmacol 1998;32:129-33.
77. Domenech VS, Nylen ES, White JC, Snider RH, Becker KL, Landmann R, et al. Calcitonin gene-related peptide expression in sepsis: Postulation of microbial infection-specific response elements within the calcitonin I gene promoter. J Investig Med 2001;49:514-21.
78. Zhou M, Arthur AJ, Ba ZF, Chaudry IH, Wang P. The small intestine plays an important role in upregulating CGRP during sepsis. Am J Physiol Regul Integr Comp Physiol 2001;280:382-8.
79. Booth BP, Tabrizi-Fard MA, Fung H. Calcitonin gene-related peptide-dependent vascular relaxation of rat aorta. An additional mechanism for nitroglycerin. Biochem Pharmacol 2000;59:1603-9.
80. Paolocci N, Katori T, Champion HC, St John ME, Miranda KM, Fukuto JM, et al. Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: Independence from β-adrenergic signaling. Proc Natl Acad Sci USA 2003;100: 5537-42.
81. Ghatta S, O'Rourke ST. Role of endogenous CGRP in the development of nitrate tolerance. FASEB J 2004;18:984.
82. Zhou ZH, Jiang JL, Peng J, Deng HW, Li YJ. Reversal of tolerance to nitroglycerin with N-acetylcysteine or captopril: a role of calcitonin gene-related peptide. Eur J Pharmacol 2002;439:129-34.
83. Wu D, Bassuk J, Adams JA. Calcitonin gene-related peptide protects against whole body ischemia in a porcine model of cardiopulmonary resuscitation. Resuscitation 2003;59:139-45.
84. Fernandez-Patron C, Stewart KG, Zhang Y, Koivunen E, Radomski MW, Davidge ST. Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res 2000;87:670-6.
85. Takeba Y, Suzuki N, Kaneko A, Asai T, Sakane T. Evidence for neural regulation of inflammatory synovial cell functions by secreting calcitonin gene-related peptide and vasoactive intestinal peptide in patients with rheumatoid arthritis. Arthritis Rheum 1999;42:2418-29.
86. Elhawary AM, Poon JS, Pang CC. Receptor subtypes mediating renal actions of calcitonin gene-related peptide. Eur J Pharmacol 1995;286:255-63.
87. Yuzurihara M, Ikarashi Y, Noguchi M, Kase Y, Takeda S, Aburada M. Involvement of calcitonin gene-related peptide in elevation of skin temperature in castrated male rats. Urology 2003;62:947-51.
88. Kline LW, Pang PK. The effect of body weight on the calcitonin gene-related peptide-induced relaxation of guinea pig gallbladder strips. Regul Pept 1995;59:97-101.
89. Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC. Neuropeptides in the skin: Interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998;7:81-96.